Pharmacological Research · 2023 · 14 citations · 38 references
MedicineMolecular BiologyOncologyCarcinogenesisMolecular OncologyTumor ProgressionCancer Cell SignalingMetastatic Breast CancerOncogenic Signaling PathwaysSignal Transduction In CancerTargeted Cancer TherapyTumor Suppressor GenesBreast Cancer PrognosisBreast Cancer ProgressionHigh-mobility Group Box 1 ProteinMalignant ProgressionMatrix MetalloproteinasesProtein Expression LevelsTumor Suppressor LossTumor Suppressor Pathways
Malignant proliferation and metastasis are the main causes of breast cancer death. The transcription factor high mobility group (HMG) box-containing protein 1 (HBP1) is an important tumor suppressor whose deletion or mutation is closely related to the appearance of tumors. Here, we investigated the role of HBP1 in breast cancer suppression. HBP1 enhances the activity of the tissue inhibitors of metalloproteinases 3 (TIMP3) promoter, thereby increasing protein and mRNA levels of TIMP3. TIMP3 increases the phosphatase and tensin homolog (PTEN) protein level by inhibiting its degradation and acts as a metalloproteinase inhibitor to inhibit the protein levels of MMP2/9. In this study, we demonstrated that the HBP1/TIMP3 axis plays a crucial role in inhibiting the tumorigenesis of breast cancer. HBP1 deletion interferes with the regulation of the axis and induces the occurrence and malignant progression of breast cancer. In addition, the HBP1/TIMP3 axis promotes the sensitivity of breast cancer to radiation therapy and hormone therapy. Our study opens new perspectives on the treatment and prognosis of breast cancer.
38
Paul L. Nguyen, Alphonse G. Taghian, Matthew S. Katz et al. · Journal of Clinical Oncology · 2008 · 819 citations · Full text
Medicine, Oncology, Breast Oncology +16
Andrew H. Baker, A B Zaltsman, Sarah J. George et al. · Journal of Clinical Investigation · 1998 · 466 citations · Full text
Marilyn L. Fitzgerald, Zihua Wang, Pyong Woo Park et al. · The Journal of Cell Biology · 2000 · 424 citations · Full text